Search results
Bharti Airtel: JPM raises to ‘overweight,’ sees stronger earnings
Investing.com· 6 hours agoBharti Airtel: JPM raises to ‘overweight,’ sees stronger earnings
Want Weight Loss Pills? Here's How to Ask Your Doctor For Them
MediaFeed via AOL· 18 minutes agoWhether it’s with your spouse, your BFF or your doctor, weight loss can be a tricky topic of...
Stephens Reiterates “Overweight” Rating for 908 Devices (NASDAQ:MASS)
ETF DAILY NEWS· 4 hours agoStephens reaffirmed their overweight rating on shares of 908 Devices (NASDAQ:MASS – Free Report) in a research note published on Monday, Benzinga reports. The company has ...
‘Fight of the ages’: ‘Gypsy King’ Fury eyeing money, glory and legacy
Al Jazeera· 2 hours agoWhile the rest of the boxing world is drooling in anticipation of a genuine heavyweight world title...
Citi upgrades India to "overweight" citing stable earnings, economic growth
Reuters via Yahoo Finance· 6 days agoCitigroup analysts upgraded India to "overweight" from "neutral" in their emerging markets...
Morgan Stanley Boosts Intuit (NASDAQ:INTU) Price Target to $740.00
ETF DAILY NEWS· 4 hours agoMorgan Stanley currently has an overweight rating on the software maker’s stock. A number of other equities research analysts also recently weighed in on the stock. Barclays ...
Those with overweight or obesity more likely to be absent from work due to ill health than those...
Medical Xpress· 3 days agoIndividuals living with overweight or obesity are more likely to be absent from work due to ill...
Malibu Boats (NASDAQ:MBUU) Rating Increased to Hold at StockNews.com
ETF DAILY NEWS· 5 hours agoKeyCorp reduced their price target on shares of Malibu Boats from $50.00 to $38.00 and set an “...
Piper Sandler bullish on Context Therapeutics stock, cites CTIM-76 program By Investing.com
Investing.com· 3 hours agoOn Thursday, Piper Sandler initiated coverage on Context Therapeutics (NASDAQ:CNTX) stock, assigning...
NCR Voyix (NYSE:VYX) Earns “Overweight” Rating from Stephens
ETF DAILY NEWS· 9 hours agoStephens reiterated their overweight rating on shares of NCR Voyix (NYSE:VYX – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. Several ...